Caption Management, LLC Mersana Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$3.08 - $9.55 $799,260 - $2.48 Million	-259,500 Reduced 34.84%	485,300 $1.6 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $2.82 Million - $4.95 Million	704,800 Added 1762.0%	744,800 $3.06 Million
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $226,000 - $314,400	40,000 New	40,000 $234,000
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $482,265 - $835,380	-31,500 Reduced 25.4%	92,500 $1.5 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $2.09 Million - $3.42 Million	124,000 New	124,000 $3.3 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $157M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.